---
title: Immunophenotyping
description: Discover TD2's Immunophenotyping tool for monitoring drug treatment, or disease status and progression.
image: https://td2inc.com/hubfs/Assets/Images/og-home.jpg
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# Immunophenotyping

Immunophenotyping is a tool used to profile immune cells in peripheral blood, tissues and tumor samples. Combinations of antibodies, tagged with different fluorochomes, are used to detect proteins on the cell surface or within the cell (intracellular). Labeled cells are then acquired on a flow cytometer. TD2 has extensive experience designing immunophenotyping panels, from standard panels, to more complex panels that include activation markers, exhaustion markers, intracellular cytokines, and phosphorylation of intracellular proteins. We currently support immunophenotyping across multiple species, including human, non-human primate, canine, pig, mouse and rat.

For example, standard TBNK panels are gated through CD45+ Lymphocytes to CD3+ cells, and then to CD4 (T Helper) and CD8 (T Effector) populations. B cells are identified as CD3-CD20+ and NK cells as CD3-CD16+. Examples of Non-Human Primate (A) and Human (B) TBNK Panels are shown below.

![](https://td2inc.com/hubfs/immunophenotyping-fig-a-b.jpg)

### Request more information about Immunophenotyping

Contact our experts to help advance your drug development with TD2's trusted Flow Cytometry Services.

We have the ability to measure 10-colors/parameters within a single tube. We can further indentify T cell subsets (Central Memory, Effector Memory, Regulatory T cells, Exhausted T cells). For example, in panel C, Human CD4 cells are gated from CD45+ Lymphocytes, and further gated by CD45RA vs CCR7 to define memory subsets, or to Regulatory T cells.

![](https://td2inc.com/hs-fs/hubfs/immunophenotyping-fig-c.jpg?width=900&name=immunophenotyping-fig-c.jpg)

In addition, the functional/activation status of these T cell subsets can be measured: in Panel D, Ki67 marks proliferation in CD8 cells, and PD-1 and CD69 are used to assess activation. Only CD8 cells are shown, but the same analysis can be applied to CD4 cells.

![](https://td2inc.com/hs-fs/hubfs/immunophenotyping-fig-d.jpg?width=800&name=immunophenotyping-fig-d.jpg)

But, it’s not all about T cells: Immunophenotyping can be used to identify Subsets of B cells. In Panel E, from the lymphocyte gate, B cells are gated by CD19 vs CD20. CD19+ cells are further gated to Memory and Naïve B cell subsets. Plasma cells can also be quantitated With the Addition of CD38 to the panel.

![](https://td2inc.com/hs-fs/hubfs/immunophenotyping-fig-e.jpg?width=800&name=immunophenotyping-fig-e.jpg)

Humanized mice are genetically immune-deficient mice that have been engrafted with human stem cells to reconstitute a human immune system. They provide an invaluable tool for studying human immune cell function and the effects of drugs on human immune cells. Immunophenotyping can be done by first separating human leukocytes (hCD45+) from existing mouse leukocytes (mCD45+) Next, T cells are gated by CD3, and finally, CD4 and CD8 populations determined. Although not shown, further subsets of T cells and their activation/proliferation can be determined.

![](https://td2inc.com/hs-fs/hubfs/immunophenotyping-fig-f.jpg?width=800&name=immunophenotyping-fig-f.jpg)

Immunophenotyping is an essential tool for monitoring drug treatment, or disease status and progression.

We are pleased to offer the following immunophenotyping panels.

- Standard T cell, B Cell and NK Panels (TBNK)
- Regulatory T cells
- Memory, Naïve and Effector T cells
- TH1/TH2/TH17/TH9 T cells
- T cell activation/proliferation
- Intracellular Cytokines
- Phospho pERK, pAKT, pSTAT1, pSTAT5
- Memory B cells and Plasma Cells
- Humanized Mouse Immunophenotyping
- Customized Immunophenotyping Panels

TD2 is also excited to announce the addition of Cytek Aurora instrumentation to expand our antibody panel configurations to 20+ colors. These expanded panels are available for use on exploratory projects.

## Additional Resources

[![Development of a Receptor Occupancy Assay for a Therapeutic Bi-Specific Antibody](https://td2inc.com/hubfs/poster-219-thumb-2.jpg)](https://td2inc.com/poster-development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody?hsLang=en)

Flow

## [Development of a Receptor Occupancy Assay for a Therapeutic Bi-Specific Antibody](https://td2inc.com/poster-development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody?hsLang=en)

[![Measurement of Basophil Activation Using a Flow Cytometry Method for Applications in Clinical Research and Clinical Trials](https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg)](https://td2inc.com/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method-for-applications-in-clinical-research-and-clinical-trials?hsLang=en)

Flow

## [Measurement of Basophil Activation Using a Flow Cytometry Method for Applications in Clinical Research and Clinical Trials](https://td2inc.com/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method-for-applications-in-clinical-research-and-clinical-trials?hsLang=en)

[![Optimizing Specimen Stability – A Comparative Analysis of Shipping Protocols](https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png)](https://td2inc.com/wp-optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols?hsLang=en)

Flow

## [Optimizing Specimen Stability – A Comparative Analysis of Shipping Protocols](https://td2inc.com/wp-optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols?hsLang=en)

[![Design and Validation of a Model of a Receptor Occupancy Assay for a New Immunotherapy in Human Whole Blood Specimens](https://td2inc.com/hubfs/flow-poster-thumb.png)](https://td2inc.com/sitc-2024-poster-design-and-validation-of-a-model-of-a-receptor-occupancy-assay?hsLang=en)

Flow

## [Design and Validation of a Model of a Receptor Occupancy Assay for a New Immunotherapy in Human Whole Blood Specimens](https://td2inc.com/sitc-2024-poster-design-and-validation-of-a-model-of-a-receptor-occupancy-assay?hsLang=en)

[![Comprehensive Oncology Ecosystem](https://td2inc.com/hubfs/Oncology-Ecosystem.jpeg)](https://td2inc.com/welcome-to-td2s-comprehensive-oncology-ecosystem?hsLang=en)

Regulatory, Clinical, Preclinical, PK/ADME, Flow

## [Comprehensive Oncology Ecosystem](https://td2inc.com/welcome-to-td2s-comprehensive-oncology-ecosystem?hsLang=en)

[![Flow Cytometry-Based Receptor Occupancy Assays: Technical Challenges and Applications in Drug Development](https://td2inc.com/hubfs/flow-wp-thumb.png)](https://td2inc.com/wp-flow-cytometry-based-receptor-occupancy-assays?hsLang=en)

Flow

## [Flow Cytometry-Based Receptor Occupancy Assays: Technical Challenges and Applications in Drug Development](https://td2inc.com/wp-flow-cytometry-based-receptor-occupancy-assays?hsLang=en)

[![Flow cytometry evaluation of cell cycle arrest in A549 human non-small cell lung cancer cells and tumors following treatment with cell cycle inhibitors: A multifaceted approach to targeting cancer](https://td2inc.com/hubfs/Assets/Images/510.png)](https://td2inc.com/aacr-2024-poster-510?hsLang=en)

Flow

## [Flow cytometry evaluation of cell cycle arrest in A549 human non-small cell lung cancer cells and tumors following treatment with cell cycle inhibitors: A multifaceted approach to targeting cancer](https://td2inc.com/aacr-2024-poster-510?hsLang=en)

[![Immunophenotyping Pig Immune Cells by Flow Cytometry: A Powerful Tool for Pharmacology and Toxicology Studies](https://td2inc.com/hubfs/Assets/Images/flow-thumb-9.png)](https://td2inc.com/lp-fcsl-poster-2024-immunophenotyping-pig-immune-cells-by-flow-cytometry-a-powerful-tool-for-pharmacology-and-toxicology-studies/?hsLang=en)

Flow

## [Immunophenotyping Pig Immune Cells by Flow Cytometry: A Powerful Tool for Pharmacology and Toxicology Studies](https://td2inc.com/lp-fcsl-poster-2024-immunophenotyping-pig-immune-cells-by-flow-cytometry-a-powerful-tool-for-pharmacology-and-toxicology-studies/?hsLang=en)

[![Flow Cytometry Application in Water Microbiology: Testing Bacterial Content in Water](https://td2inc.com/hubfs/Assets/Images/flow-thumb-8.png)](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-application-in-water-microbiology/?hsLang=en)

Flow

## [Flow Cytometry Application in Water Microbiology: Testing Bacterial Content in Water](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-application-in-water-microbiology/?hsLang=en)

[![Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping](https://td2inc.com/hubfs/Assets/Images/flow-thumb-7.png)](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-processing-and-analysis-of-tumor-specimens/?hsLang=en)

Flow

## [Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-processing-and-analysis-of-tumor-specimens/?hsLang=en)

[![Flow Cytometry Based Assessment of Innate Immune Function Using Phagocytosis and Reactive Oxygen Species Measurement](https://td2inc.com/hubfs/Assets/Images/flow-thumb-6.png)](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-based-assessment-of-innate-immune-function-using-phagocytosis-and-reactive-oxygen-species-measurement/?hsLang=en)

Flow

## [Flow Cytometry Based Assessment of Innate Immune Function Using Phagocytosis and Reactive Oxygen Species Measurement](https://td2inc.com/lp-fcsl-poster-2024-flow-cytometry-based-assessment-of-innate-immune-function-using-phagocytosis-and-reactive-oxygen-species-measurement/?hsLang=en)

[![Measurement of Cytokine mRNA Expression by Flow Cytometry Using the Branched DNA Technology](https://td2inc.com/hubfs/Assets/Images/flow-thumb-5.png)](https://td2inc.com/lp-fcsl-poster-2024-measurement-of-cytokine-mrna-expression/?hsLang=en)

Flow

## [Measurement of Cytokine mRNA Expression by Flow Cytometry Using the Branched DNA Technology](https://td2inc.com/lp-fcsl-poster-2024-measurement-of-cytokine-mrna-expression/?hsLang=en)

[![10-Color Flow Cytometry Panels for the Evaluation of T Cell Subsets Such as TH Subsets, T Cell Activation, and T Regulatory Cells for Application in Clinical Trials](https://td2inc.com/hubfs/Assets/Images/flow-thumb-4.png)](https://td2inc.com/lp-fcsl-poster-2024-10-color-flow-cytometry-panels-for-the-evaluation-of-t-cell-subsets/?hsLang=en)

Flow

## [10-Color Flow Cytometry Panels for the Evaluation of T Cell Subsets Such as TH Subsets, T Cell Activation, and T Regulatory Cells for Application in Clinical Trials](https://td2inc.com/lp-fcsl-poster-2024-10-color-flow-cytometry-panels-for-the-evaluation-of-t-cell-subsets/?hsLang=en)

[![The Advantages of Fluorescent Barcoding of Human Cells Using Flow Cytometry for High Throughput Testing With an Application For Human Clinical Trials](https://td2inc.com/hubfs/Assets/Images/flow-thumb-3.png)](https://td2inc.com/lp-fcsl-poster-2024-the-advantages-of-fluorescent-barcoding-of-human-cells-using-flow-cytometry/?hsLang=en)

Flow

## [The Advantages of Fluorescent Barcoding of Human Cells Using Flow Cytometry for High Throughput Testing With an Application For Human Clinical Trials](https://td2inc.com/lp-fcsl-poster-2024-the-advantages-of-fluorescent-barcoding-of-human-cells-using-flow-cytometry/?hsLang=en)

[![The Activation Profiling of Stat in Human Whole Blood Samples By Flow Cytometry With an Application for Human Clinical Trials](https://td2inc.com/hubfs/Assets/Images/flow-poster-2.png)](https://td2inc.com/lp-fcsl-poster-2024-the-activation-profiling-of-stat-in-human-whole-blood-samples/?hsLang=en)

Flow

## [The Activation Profiling of Stat in Human Whole Blood Samples By Flow Cytometry With an Application for Human Clinical Trials](https://td2inc.com/lp-fcsl-poster-2024-the-activation-profiling-of-stat-in-human-whole-blood-samples/?hsLang=en)

[![Design and Validation of a Model of a Receptor Occupancy Assay for a New Immunotherapy in Human Whole Blood Specimens](https://td2inc.com/hubfs/Assets/Images/flow-poster-1.png)](https://td2inc.com/lp-fcsl-poster-2024-design-and-validation-of-a-model-of-a-receptor-occupancy-assay/?hsLang=en)

Flow

## [Design and Validation of a Model of a Receptor Occupancy Assay for a New Immunotherapy in Human Whole Blood Specimens](https://td2inc.com/lp-fcsl-poster-2024-design-and-validation-of-a-model-of-a-receptor-occupancy-assay/?hsLang=en)

Load More

## GET STARTED

## Work with a team who believes in your research as much as you do.

Are you ready to start your Flow Cytometry studies? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

×

![Receptor Occupancy](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-10.png?width=65&name=icon-10.png)**Receptor Occupancy**

### Binding of fluorophore labeled “drug” in relation to decreasing dose of unlabeled “drug”

![Receptor Occupancy](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/receptor-occupancy-1.png?width=780&name=receptor-occupancy-1.png)

![Receptor Occupancy](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-10.png?width=65&name=icon-10.png)Receptor Occupancy

×

![PBMC Services](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-testtube.png?width=65&name=icon-testtube.png)**PBMC Services**

### Evaluate responses of PBMCs by profiling the function/phenotype of subpopulations

![PBMC Services](https://td2inc.com/hs-fs/hubfs/Assets/Images/pbmc-isolation-1.png?width=549&name=pbmc-isolation-1.png)

×

![Immune Population Phenotyping](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-analysis-biological.png?width=65&name=icon-analysis-biological.png)**Immune Population Phenotyping**

### Immune cell population analysis of subcutaneous CT26 murine colon carcinoma tumors

CT26 SC tumors: Gating strategy T cells and NK cells.

Gating involved identifying the total cell population, and then gate out the doublets, gate out the dead cells, move on to our first marker CD45 which gates out any non-immune cells. The bottom right cytogram shows the different NK cell populations. The far left middle cytogram depicts the two T cell population CD4+ and CD8+. Values are % of total CD45+ cells.

![Immune Population Phenotyping](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/immune-population-phenotyping.png?width=920&name=immune-population-phenotyping.png)

×

![Cancer Cells/ Tumor Specific Marker Expression](https://td2inc.com/hs-fs/hubfs/Assets/Icon/immune-population.png?width=65&name=immune-population.png)**Cancer Cells/Tumor Specific Marker Expression**

### Cancer cells/tumors specific markers expression

- Viability dye inclusion
- Cell lines and single-cell suspension tumors
- Surface staining

![Cancer Cells/Tumor Specific Marker Expression](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/tumor-specific-marker-expression.png?width=920&name=tumor-specific-marker-expression.png)

×

![Fluorescent Proteins Expression](https://td2inc.com/hs-fs/hubfs/Assets/Icon/fluorescent-proteins.png?width=65&name=fluorescent-proteins.png)**Fluorescent Proteins Expression**

### Fluorescent proteins expression

- Viability dye inclusion
- Cell lines and transfected primary cells
- Surface staining

![Fluorescent Proteins Expression](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/fluorescent-proteins-expression.png?width=920&name=fluorescent-proteins-expression.png)

×

![Cell Cycle Analysis](https://td2inc.com/hs-fs/hubfs/Assets/Icon/cell-cycle.png?width=65&name=cell-cycle.png)**Cell Cycle Analysis**

### Cell cycle analysis A549 cells

- Propidium iodide
- Cell lines

![Cell Cycle Analysis](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/cell-cycle-analysis.jpg?width=920&name=cell-cycle-analysis.jpg)

×

![Intracellular Protein Analysis](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-9.png?width=65&name=icon-9.png)**Intracellular Protein Analysis**

- Intracellular Cytokines
- Phosphorylated Proteins
- T-Regs
- Phosphoroteins
- Cytokines

![Intracellular Protein Analysis](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/intracelluar-1.png?width=475&name=intracelluar-1.png)

×

![Cellular Functional Assays](https://td2inc.com/hs-fs/hubfs/Assets/Icon/icon-dropper.png?width=65&name=icon-dropper.png)**Cellular Functional Assays**

- NK Cell Function
- Basophil Activation Test (BAT)

![Cellular Functional Assays](https://td2inc.com/hs-fs/hubfs/Assets/GraphsFigures/celluar-functional-assays-1.png?width=484&name=celluar-functional-assays-1.png)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)